Skip to main content
CHC logo

CHC — Investor Relations & Filings

Ticker · 4164 ISIN · TW0004164009 TW Wholesale and retail trade
Filings indexed 2,275 across all filing types
Latest filing 2018-11-12 Capital/Financing Update
Country TW Taiwan
Listing TW 4164

About CHC

www.chcg.com

CHC Healthcare Group is a provider of comprehensive medical equipment, technology, and management services. The company offers one-stop solutions ranging from equipment distribution and leasing to operational consulting and hospital management. Its extensive portfolio covers specialized fields such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, dentistry, and rehabilitation. Representing over 30 international brands, the group is a major distributor of high-end medical devices and a leader in oncology equipment. Beyond equipment sales and maintenance, the company has expanded into long-term care, radiation sterilization services, and chain pharmacy channels. With a focus on smart healthcare and advanced medical technologies, the group supports healthcare providers through technical maintenance, personnel training, and integrated department construction across the Asia-Pacific region.

Recent filings

Filing Released Lang Actions
[更正公告]代重要子公司久和醫療(股)公司公告董事會決議 現金增資
Capital/Financing Update Classification · 95% confidence The document is a short announcement (791 characters) about a board resolution regarding a cash capital increase by a major subsidiary. It includes details such as the number of shares issued, price, and purpose of the capital increase. There is no financial statement or comprehensive report content. The document is an update on financing activity, specifically a capital increase. According to the definitions, this fits best under Capital/Financing Update (CAP). The document is not a full report, nor an announcement of a report publication, so RPA is not appropriate. Confidence is high due to clear content and format.
2018-11-12 Chinese
[更正公告]本公司董事會通過對重要子公司久和醫療儀器(股)公司 現金增資
Capital/Financing Update Classification · 95% confidence The document is a disclosure announcement from a listed company (4164 承業醫) regarding a board-approved capital increase (cash injection) into an important subsidiary (久和醫療儀器). It details the transaction specifics such as share quantity, price, total amount, relationship between parties, decision process, and dates. The document is short (1773 characters) and focuses on a specific financing transaction rather than a full financial report or earnings release. It is not a full annual or interim report, nor a call transcript or AGM material. The content fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. Therefore, the correct classification is CAP with high confidence.
2018-11-12 Chinese
本公司資金貸與餘額達「公開發行公司資金貸與及背書保證處理準 則」第二十二條第一項第三款之公告標準
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a publicly listed company (4164 承業醫) disclosing details about funds lent to its subsidiaries, including amounts, terms, and related financial information. It references compliance with specific regulatory standards for public companies regarding fund lending and guarantees. The document length is short (1297 characters) and it primarily serves as a disclosure of a specific financial transaction rather than a full financial report or earnings release. There is no indication of it being an annual or interim report, audit report, or earnings release. It is not a management or board change announcement, nor a voting result or dividend notice. The content fits best with a regulatory filing category that covers miscellaneous compliance disclosures and announcements that do not fit other specific categories.
2018-11-12 Chinese
公告本公司提報董事會民國107年第三季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a company (承業醫) reporting the submission of its consolidated financial report for the third quarter of the year 107 (Taiwanese calendar, corresponding to 2018). It includes key financial figures such as net revenue, operating profit, net profit, and earnings per share for the quarter. The document is short (784 characters) and primarily serves as a notification of the filing of the quarterly financial report to the board, rather than containing the full detailed financial statements or comprehensive analysis itself. Therefore, it is best classified as an Interim / Quarterly Report (IR), as it contains substantive financial data for a period shorter than a full fiscal year.
2018-11-12 Chinese
107年10月營業收入
Regulatory Filings Classification · 95% confidence The document is a brief tabular summary listing company codes and names, with a note about monthly revenue reporting by subsidiaries under ROC or IFRS standards. It contains no financial statements, no detailed report content, no management discussion, no voting results, no legal or regulatory announcements, and no indication of a specific report being attached or published. The document length is very short (629 characters), and it appears to be a general regulatory disclosure or informational filing rather than a full report or announcement. Given the lack of specific report content and the nature of the data, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2018-11-12 Chinese
107年10月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company, containing tables of financial data related to loan balances and guarantee information for the current and previous months, as well as cumulative amounts and limits. The data is presented in a concise format with no narrative or detailed analysis. The document length is very short (680 characters), and it primarily provides a snapshot of financial figures without comprehensive financial statements or management discussion. It does not appear to be a full financial report like an Annual Report (10-K) or Interim Report (IR), nor is it a regulatory certification or announcement of a report. Given the nature of the data (financial figures on loans and guarantees) and the short length, this fits best as a Regulatory Filing (RNS), which is a general category for miscellaneous regulatory disclosures that do not fit other specific categories.
2018-11-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.